These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12566379)

  • 1. Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Sobel BE; Frye R; Detre KM;
    Circulation; 2003 Feb; 107(4):636-42. PubMed ID: 12566379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Goldfine AB; Fonseca V
    Circulation; 2010 Jun; 121(22):2447-9. PubMed ID: 20530022
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Magee MF; Isley WL;
    Am J Cardiol; 2006 Jun; 97(12A):20G-30G. PubMed ID: 16813735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular clinical trials in patients with diabetes mellitus: lessons from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study.
    Solomon SD
    Circulation; 2010 Jun; 121(22):2453-5. PubMed ID: 20530024
    [No Abstract]   [Full Text] [Related]  

  • 5. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
    J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.
    Bittner V; Bertolet M; Barraza Felix R; Farkouh ME; Goldberg S; Ramanathan KB; Redmon JB; Sperling L; Rutter MK;
    J Am Coll Cardiol; 2015 Aug; 66(7):765-773. PubMed ID: 26271057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).
    Schwartz L; Kip KE; Alderman E; Lu J; Bates ER; Srinivas V; Bach RG; Mighton LD; Feit F; King S; Frye RL;
    Am J Cardiol; 2009 Mar; 103(5):632-8. PubMed ID: 19231325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D).
    Schwartz L; Bertolet M; Feit F; Fuentes F; Sako EY; Toosi MS; Davidson CJ; Ikeno F; King SB
    Circ Cardiovasc Interv; 2012 Apr; 5(2):166-73. PubMed ID: 22496082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General cardiology perspective: decision making regarding revascularization of patients with type 2 diabetes mellitus and cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Fuster V; Farkouh ME
    Circulation; 2010 Jun; 121(22):2450-2. PubMed ID: 20530023
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Brooks MM; Frye RL; Genuth S; Detre KM; Nesto R; Sobel BE; Kelsey SF; Orchard TJ;
    Am J Cardiol; 2006 Jun; 97(12A):9G-19G. PubMed ID: 16813734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group
    Am Heart J; 2008 Sep; 156(3):528-536, 536.e1-5. PubMed ID: 18760137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of the BARI 2D and COURAGE trials: overview.
    Brooks MM; Boden WE; Frye RL
    Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study.
    Srinivas VS; Brooks MM; Detre KM; King SB; Jacobs AK; Johnston J; Williams DO
    Circulation; 2002 Sep; 106(13):1627-33. PubMed ID: 12270854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal care of patients with type 2 diabetes mellitus and coronary artery disease.
    Frye RL
    Am J Med; 2003 Dec; 115 Suppl 8A():93S-98S. PubMed ID: 14678873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Chung MJ; Novak E; Brown DL
    Coron Artery Dis; 2017 Jun; 28(4):301-306. PubMed ID: 28346285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.
    Dagenais GR; Lu J; Faxon DP; Bogaty P; Adler D; Fuentes F; Escobedo J; Krishnaswami A; Slater J; Frye RL;
    J Am Coll Cardiol; 2013 Feb; 61(7):702-11. PubMed ID: 23410541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes).
    Chung SC; Hlatky MA; Faxon D; Ramanathan K; Adler D; Mooradian A; Rihal C; Stone RA; Bromberger JT; Kelsey SF; Brooks MM;
    J Am Coll Cardiol; 2011 Aug; 58(8):810-9. PubMed ID: 21835316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Brooks MM; Chung SC; Helmy T; Hillegass WB; Escobedo J; Melsop KA; Massaro EM; McBane RD; Hyde P; Hlatky MA;
    Circulation; 2010 Oct; 122(17):1690-9. PubMed ID: 20937978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factor control for coronary artery disease secondary prevention in large randomized trials.
    Farkouh ME; Boden WE; Bittner V; Muratov V; Hartigan P; Ogdie M; Bertolet M; Mathewkutty S; Teo K; Maron DJ; Sethi SS; Domanski M; Frye RL; Fuster V
    J Am Coll Cardiol; 2013 Apr; 61(15):1607-15. PubMed ID: 23500281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
    Sobel BE
    Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.